Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma

This study has been completed.
Information provided by (Responsible Party):
GW Research Ltd Identifier:
First received: March 14, 2013
Last updated: August 10, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2016
  Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)